TABLE 4
Association of UGT1A1*28 promoter polymorphisms with the novel UGT1A7 promoter polymorphism
Genotyping of 200 patients referred for suspected Gilbert-Meulengracht's disease. Among these patients, 71 were homozygous for the UGT1A7*28 TATA box polymorphism of the UGT1A1 bilirubin transferase gene. Taqman allelic discrimination PCR analysis of all 200 patients demonstrated that in persons homozygous for the UGT1A1*28 TATA box polymorphism, 73% carried the homozygous UGT1A7 â57 G promoter polymorphism, and only 2 (3%) had the wild-type UGT1A7 promoter, indicating that among patients with homozygous Gilbert-Meulengracht's disease, 97% carry the reduced activity UGT1A7 promoter polymorphism. However, UGT1A7 â57 Tâ G is also present in persons who carry a UGT1A1*1 promoter.